NBTX
Companies
NASDAQ
Nanobiotix S.A. - ADR
Health Care
$4.48
+$1.61 (+56.10%)
Price Chart
Overview
About NBTX
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Market Cap
$268.5M
Volume
75.1K
Avg. Volume
57.7K
P/E Ratio
-1.531746
Dividend Yield
0.00%
Employees
122.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.49
Low Correlation
Volatility
High (0.73)
Relative to market
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, NBTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$268.5M
Volume75.1K
P/E Ratio-1.53
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 24, 2023Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025